Imatinib-related symptom burden linked to adherence in Indian CML patients

Research shows low adherence to imatinib in Indian patients with chronic myeloid leukaemia, with an association between nonadherence and worse symptom burden related to treatment.
Source: MedWire News - Category: Consumer Health News Tags: Chronic myeloid leukaemia Source Type: news